Description: Probiotec Limited is engaged in the development, manufacture and sale of pharmaceuticals, consumer health and nutraceutical products in Australian and international markets. The Company's segments include Branded Pharmaceuticals, involving the sale of branded pharmaceutical products throughout Australia and also to selected South East Asian countries; Contract manufacture, involving the contract manufacturing of pharmaceutical, food and animal nutrition products on behalf of domestic and international pharmaceutical and food companies; Obesity and weight management, involving the manufacture and sale of a range of products across a number of channels, including fast moving consumer goods, pharmacy, health food stores and online; Europe, involving the manufacture and sale of products within Europe, and Specialty products, involving the sale of human and animal nutrition products, incorporating the sale of ingredients and additives for use in the pharmaceutical and food industries.
Home Page: www.probiotec.com.au
PBP Technical Analysis
PIMCO Equity Series
,
Phone:
61 3 9278 7555
Officers
| Name | Title |
|---|---|
| Mr. Wesley Stringer B.Comm, CPA, LLB (Hons) | CEO, MD & Exec. Director |
| Mr. Jared Stringer B.Comm, BIT, CPA | CFO, Company Sec. & Financial Controller |
| Ms. Julie McIntosh | Chief Operating Officer |
| Mr. Alan Hong | Gen. Mang. of Accounting |
| Mr. Dustin Stringer | Gen. Mang. of Marketing |
| Ms. Annalinde Nickisch | Chief People Officer |
| Ms. Jessica Walters | Chief Customer Officer |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 13.1 |
| Price-to-Book MRQ: | 2.3456 |
| Price-to-Sales TTM: | 1.0036 |
| IPO Date: | 2006-11-14 |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |